Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04168294
Other study ID # rjyyxhk2017001
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date November 14, 2019
Est. completion date November 14, 2019

Study information

Verified date November 2019
Source Shanghai Jiao Tong University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

It is commonly recommended that patients should refrain from driving for 24 hours after sedation for endoscopy,however,this recommendation has been queried recently.To investigate the effect of sedation on early postoperative cognitive function in patients undergoing endoscopy.


Description:

One hundred adult patients undergoing sedative esophagogastroduodenoscopy ( EGD) were randomly recruited,and another 100 adult patients undergoing conventional(without sedation) EGD were served as controls. All patients had an education level more than 9 years. Cognitive function was assessed by Montreal Cognitive Assessment(MoCA)1 week before EGD exam, 10 mins before propofol sedation or the beginning of endoscopic procedure, 30mins after EGD exam, and 2 week after exam.


Recruitment information / eligibility

Status Terminated
Enrollment 200
Est. completion date November 14, 2019
Est. primary completion date November 14, 2019
Accepts healthy volunteers No
Gender All
Age group 20 Years to 64 Years
Eligibility Inclusion Criteria:

1. The scores of MMSE are more than 26.

2. The AHA grade I and II.

Exclusion Criteria:

1. The AHA grade III, IV or V.

2. binge drinking.

3. Take sedatives, sleeping agents and some drug which may affect the study in a month.

4. Psychiatric disorders.

5. The dysfunction of heart, lung, liver and kidney.

Study Design


Intervention

Drug:
Propofol
patients in sedation group will be intravenous injected propofol in bolus
Device:
endoscopy
endoscopy system

Locations

Country Name City State
China Department of Gastroenterology, Renji Hospital, Shanghai Institute of Digestive Diseases, Shanghai Jiao Tong University School of Medicine Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Shanghai Jiao Tong University School of Medicine

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary NCT-A test outcome measure the score of NCT-A test for each patient is not less than that in the baseline. 30 minutes
Primary DST test outcome measure the score of DST for each patient is not less than that in the baseline. 30 minutes
Primary number cancellation test outcome measure the score of number cancellation test for each patient is not less than that in the baseline. 30 minutes
Secondary heart rate outcome measure heart rate less than 50 time per minute 5 minutes
Secondary SpO2 outcome measure SpO2 less than 90% 5 minutes
See also
  Status Clinical Trial Phase
Completed NCT02488720 - Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Recruiting NCT03544801 - Renji Cerebral Small Vessel Disease Corhort Study
Recruiting NCT02813434 - Cerebral Amyloid Imaging Using Florbetapir (AV-45) Phase 3
Completed NCT00400790 - Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane N/A
Completed NCT00052091 - Therapy for Depressed Elders With Thought Problems Phase 3
Completed NCT00021866 - Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy N/A
Completed NCT00267163 - Brain Imaging and Mental Disorders of Aging Intervention Phase 4
Not yet recruiting NCT04079075 - Multiple Interventions to Prevent Cognitive Decline N/A
Terminated NCT03696082 - A Precision Rehabilitation Approach to Counteract Age-Related Cognitive Declines N/A
Completed NCT02918539 - Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Active, not recruiting NCT01708837 - Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction Phase 4
Completed NCT01290939 - Bevacizumab and Lomustine for Recurrent GBM Phase 3
Terminated NCT00548327 - The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype Phase 2
Unknown status NCT00256425 - Cognitive Rehabilitation of Glioma Patients Phase 3
Recruiting NCT03926351 - High Dose Omega 3 in People at Risk for Dementia Phase 2
Completed NCT02118571 - Schizophrenia Cognition Scale Development N/A
Completed NCT01481961 - Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease N/A
Completed NCT00788918 - Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS) N/A
Completed NCT00564902 - The Zeaxanthin and Visual Function Study N/A
Completed NCT00529581 - A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis Phase 2